Given that (a) ECs resemble cancer cells in their preferential use of glycolysis and (b) MCT4 was markedly upregulated by endothelial PHD inactivation in the postischemic kidney, we postulated that MCT4 inhibition might promote adaptive kidney repair by suppressing endothelial glycolysis. The gene discussed is SLC16A3; the disease is cancer.